A number of firms spanning infrastructure, actual property, packaging, co-working, specialty pharma, and specialty chemical substances are in focus as brokerages have just lately assigned goal costs indicating potential upside as much as 114 p.c. Listed below are six shares highlighted by prime brokerages together with their goal costs and estimated upsides. Do you maintain any?
H.G. Infra Engineering is a well-established participant in India’s infrastructure panorama, specialising within the development of highways and highway networks for over twenty years. The corporate focuses on delivering dependable and large-scale infrastructure property that assist India’s increasing financial ambitions.
The corporate has a market cap of Rs. 5826.30 crore and the closing value as on 14th November 2025 was Rs. 894. HDFC Securities has issued a goal value of Rs. 1480, translating into a possible upside of 65.56 p.c from present ranges.
Keystone Realtors operates throughout the true property improvement worth chain, endeavor the development of residential complexes, built-in townships, industrial buildings and lifestyle-focused group areas. Its portfolio spans a number of landmark properties throughout city centres.
The corporate has a market cap of Rs. 6645.05 crore and the closing value as on 14th November 2025 was Rs. 526.55. JM Monetary has assigned a goal value of Rs. 800, implying an upside of 51.93 p.c from the closing value.
EPL is concerned in producing superior multilayer packaging supplies, together with collapsible tubes, laminates and corrugated bins used extensively throughout private care, prescribed drugs, meals, house care and oral care industries. The corporate is a most popular packaging accomplice for a number of international shopper manufacturers.
The corporate has a market cap of Rs. 6405.14 crore and the closing value as on 14th November 2025 was Rs. 200.05. ICICI Securities has given a goal of Rs. 315, indicating a possible upside of 57.45 p.c.
Awfis Area Options gives versatile workspaces, managed workplace operations and company fit-out companies. Its choices span shared workspaces, enterprise-grade workplace setups and complete facility administration options designed for contemporary companies.
The corporate has a market cap of Rs. 4071.01 crore and the closing value as on 14th November 2025 was Rs. 569.30. ICICI Securities has set a goal value of Rs. 868, suggesting an upside of 52.48 p.c.
OneSource Specialty Pharma focuses on creating, manufacturing and commercialising biologic drug merchandise throughout injectable codecs. It additionally gives full improvement and manufacturing assist for biologics by pre-clinical, medical and industrial phases.
The corporate has a market cap of Rs. 19,890.74 crore and the closing value as on 14th November 2025 was Rs. 1736.80. JM Monetary has projected a goal value of Rs. 2621, which factors to an upside potential of fifty.90 p.c.
Neogen Chemical compounds, based in 1989, is a number one Indian specialty chemical substances producer producing each bromine-based and lithium-based merchandise. Its portfolio caters to various sectors together with prescribed drugs, agrochemicals, polymers, water therapy, development chemical substances and superior battery supplies.
The corporate has a market cap of Rs. 3211.97 crore and the closing value as on 14th November 2025 was Rs. 1217.50. HDFC Securities has issued a bullish goal of Rs. 2606, providing the very best upside among the many checklist at 114.04 p.c.
Written by Manan Gangwar
Disclaimer
The views and funding suggestions expressed by funding consultants/broking homes/ranking companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of economic losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Non-public Restricted or the creator are usually not accountable for any losses prompted because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
